HENDERSON, Nev., Oct. 9, 2025 /PRNewswire/ -- VolitionRx Limited (VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today that it is proposing to offer and sell, in ...

MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (OCGN) (Ocugen or the Company), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it has ...

The MarketWatch News Department was not involved in the creation of this content. BOSTON, MASSACHUSETTS / ACCESS Newswire / October 6, 2025 / Ondas Holdings Inc. (NASDAQ:ONDS) ("Ondas" or the "Company ...

This data feed is not available at this time.

HENDERSON, Nev., Oct. 9, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today that it is proposing to ...

SAN DIEGO--(BUSINESS WIRE)--Nuvve Holding Corp. (“Nuvve” or the “Company”) (Nasdaq: NVVE), a global leader in distributed grid assets management and vehicle-to-grid (V2G) technology, today announced ...

Jefferies, TD Cowen and Piper Sandler are acting as joint book-running managers for the offering. Wedbush PacGrow and LifeSci Capital are acting as passive bookrunners for this offering.

Ondas has priced a $1 billion equity and warrant financing deal. ・The offering is priced at $16.45 per share, paired with a ...

Detailed price information for Ondas Holdings Inc (ONDS-Q) from The Globe and Mail including charting and trades.